Crescent Biopharma (CBIO) Q2 2023 Earnings

14AugConfirmed
Aug 22
Nov 22
Q1 2023
Q2 2023
-1.07
-0.17
0.74
1.64

Details

Expected EPS
-0.07
Actual EPS
-0.07
Surprise EPS
0
Surprise Percent
+0%

Description

Crescent Biopharma (CBIO) has reported earnings of -0.07 per share for Q2 2023.

0 Comments

Share your thoughts